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Aggregatibacter (Actinobacillus) actinomycetemcomitans is a facultative anaerobic gram-negative bacterium associated with
severe forms of periodontitis. A leukotoxin, which belongs to the repeats-in-toxin family, is believed to be one of its virulence
factors and to have an important role in the bacterium’s pathogenicity. This toxin selectively kills human leukocytes by inducing
apoptosisandlysis.Here,wereportthatleukotoxin-inducedcelldeathofmacrophagesproceededthroughaprocessthatdiffers
fromthe classicalcharacteristics ofapoptosisand necrosis.A. actinomycetemcomitans leukotoxin-induced several cellularand
molecular mechanisms in human macrophages that led to a speciﬁc and excessive pro-inﬂammatory response with particular
secretion of both interleukin (IL)-1b and IL-18. In addition, this pro-inﬂammatory cell death was inhibited by oxidized ATP, which
indicates involvement of the purinergic receptor P2X7 in this process. This novel virulence mechanism of the leukotoxin may
have an important role in the pathogenic potential of this bacterium and can be a target for future therapeutic agents.
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Aggregatibacter actinomycetemcomitans is a facultative
anaerobic gram-negative bacterium that is mainly associated
with severe forms of periodontitis, mankind’s most common
chronic inﬂammatory disease.
1–3 There is evidence for a
correlation between loss of attachment of the periodontal
tissue and high proportion of A. actinomycetemcomitans.
4
In addition, this bacterium has been responsible for some
non-oral infections including endocarditis, bacteremia,
pericarditis, septicemia, pneumonia, infectious arthritis,
osteomyelitis, synovitis, skin infections, urinary tract infec-
tions and various types of abscesses.
5 A link between this
bacterium and cardiovascular diseases seems to exist
since A. actinomycetemcomitans has been detected in
atherosclerotic plaque samples.
1,6
A. actinomycetemcomitans possesses several different
well-studied virulence factors, among which the leukotoxin is
suggested to have an important role in the pathogenicity.
6–7
The leukotoxin of A. actinomycetemcomitans shares con-
siderable molecular homology (35–70%) with toxins of the
repeats-in-toxin (RTX) family, which are produced by other
gram-negative pathogens, such as Escherichia coli, Actino-
bacillus pleuropneumoniae, Bordetella pertussis and
Mannheimia haemolytica.
8 The toxins of the RTX family
selectively killhumanleukocytesbyinducing apoptosis andlysis.
9
An intra-species diversity of A. actinomycetemcomitans
exists and clones with different leukotoxin-producing abilities
have been identiﬁed.
6 One clone, JP2, has enhanced
leukotoxin expression because of a 530-bp deletion in the
leukotoxin promoter region, and it is strongly correlated
to disease onset in certain populations.
10–12 The leukotoxin
is assumed to protect the bacterium from the local defense
mechanisms through its capacity to lyse human immune
cells.
13–14 However, this cytotoxic effect cannot alone explain
the inﬂammatory responses that cause the destruction of the
tooth-supporting tissues.
Macrophages have an important role in various homeo-
static, immunological and inﬂammatory processes. These
cells are organ-localized and can render an immediate
nonspeciﬁc defense against foreign elements before immi-
gration of other leukocytes. Macrophages release cytokines,
are the main source of interleukin 1b (IL-1b) in the inﬂamed
tissue, andcontribute tothespeciﬁcimmunitythroughantigen
presentation.
15–16 IL-1b is produced as a biologically inactive
precursor, pro-IL-1b, and needs to be cleaved by a speciﬁc
enzyme, caspase-1, for activation and secretion.
15 This
enzyme can be activated in response to various pore-forming
toxins and extra cellular ATP.
17 Human monocytes/macro-
phages are highly sensitive to the A. actinomycetemcomitans
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www.nature.com/cddisleukotoxin. In contrast to other subsets of leukocytes, the
monocytes/macrophages are lysed by a mechanism that
involves activation of caspase-1 and secretion of bio-active
IL-1b.
18–19 This response is mediated by leukotoxin or live
wild-type A. actinomycetemcomitans. As the response is
completely abolished in the presence of bacteria from a
leukotoxin knockout strain, the induced IL-1b secretion from
these cells appears mainly to be caused by the leukotoxin.
20
These ﬁndings resembles a recently discovered death
mechanism termed pyroptosis, which is characterized as a
caspase-1-dependent programmed cell death leading speci-
ﬁcally to IL-1b and IL-18 secretion.
21 Pyroptosis was ﬁrst
described for Salmonella-infected macrophages.
22
In this study, we describe new features of human macro-
phage cell death induced by A. actinomycetemcomitans
leukotoxin that that can be linked to pathogenic mechanisms
of inﬂammatory-related diseases.
Results
Cell survival and cell death of macrophages exposed to
leukotoxin. The lactate dehydrogenase (LDH) leakage from
human macrophages exposed to various concentrations of
A. actinomycetemcomitans leukotoxin for 60min indicated
that a dose-dependent disruption of the membrane integrity
occurred when leukotoxin concentrations were Z1ng/ml
(Figure 1a). The uptake of early apoptotic (Yo-PRO-1) and
necrotic/late apoptotic (propidium iodide, PI) markers in
macrophages exposed to 1 or 10ng/ml of leukotoxin (60min)
showed a similar pattern for both markers (Figure 1b).
The morphology of the macrophages exposed to these
concentrations of leukotoxin for 60min was further analyzed
by transmission electron microscopy (TEM) (Figure 1c). The
proportion of normal cells (Figure 1c-i) decreased, while the
proportions of necrotic cells (Figures 1c-II and c-IV) and
apoptotic cells (Figures 1c-III and c-V) increased. Leukotoxin
caused an activation and secretion of IL-18 and IL-1b from
the affected macrophages (Figures 2d and e). Taken
together, these results indicated that there existed a
threshold level for leukotoxin sensitivity in each cell and
that each of the affected cells activated signaling pathways
that eventually led to cell death.
Effects of leukotoxin on macrophage IL-1b production
and secretion. The amounts of total active IL-1b (cell
associated and secreted), detectable by enzyme-linked
immunosorbent assay (ELISA), from macrophages
exposed to 10ng/ml of A. actinomycetemcomitans leuko-
toxin or to 100ng/ml of E. coli lipopolysaccharide (LPS) for
180min are shown (Figure 2a). Cultures of macrophages
exposed for 60min to A. actinomycetemcomitans leukotoxin
(10ng/ml) showed a 10-fold increase in total IL-1b protein as
compared with cultures without stimulus and a 6-fold
increase as compared with cultures exposed to E. coli LPS
(100ng/ml) (Figure 2a). To study whether this excessive
secretion could be due to higher production of IL-1b, the
mRNA level for this cytokine in macrophages was studied by
quantitative real-time RT-PCR. The IL-1b mRNA level in the
macrophages exposed to leukotoxin for 60min was negligibly
increased as compared with the control cells, while exposure
to LPS (100ng/ml) led to approximately 30 times higher
levels of IL-1b mRNA (Figure 2b). Time-course experiments
aimed to study the mRNA levels of IL-1b showed no sign of
any marked increase because of the leukotoxin exposure
(Figure 2c). On the other hand, the time course of the
secreted active protein showed that already after 20min
of leukotoxin exposure (10ng/ml) a substantial amount of
IL-1b was secreted and reached its maximum after
40min (Figure 2d). The enhancement caused by the LPS
(100ng/ml) after 60-min exposure was negligible as
compared with that caused by the leukotoxin (Figure 2d).
All the mRNA levels for IL-1b were calculated in relation to
the mRNA levels of an endogenous control, glyceraldehyde-
3-phosphate dehydrogenase (GAPDH). To verify the stability
of GAPDH mRNA in the leukotoxin-exposed macrophages,
the mRNA levels of another endogenous control, ribosomal
protein L13A (RPL13A), were also quantiﬁed. The resulting
changes in the IL-1b mRNA levels because of exposure to
leukotoxin or LPS were similar regardless of the selection of
the endogenous controls tested (data not shown).
Leukotoxin exposure (10ng/ml) of macrophages for 60min
decreased the cell-associated pro-IL-1b and increased the
secretion of pro-IL-1b (Figure 2e). In addition, the secreted
IL-1b was substantially increased by leukotoxin. Heat
inactivation of leukotoxin completely abolished its ability to
cause secretion of the pro-form, as well as the active IL-1b.
Heat inactivation of the leukotoxin completely abolished its
ability to induce IL-1b secretion and the leukotoxin did not
affect the pro-IL-b production, neither the native nor the heat
inactivated, which indicates no effect from non-proteinaceous
contaminants(i.e.,LPS). Thetotallevelofcell-associatedand
secreted IL-1b (pro- and active forms, taken together) from
macrophages exposed to leukotoxin (10ng/ml) for 60min,
increased two times as compared with the unchallenged cells
(Figure 2e). Western blot analyses of macrophage cultures
exposed to leukotoxin (10ng/ml) or LPS (100ng/ml) for
60min, conﬁrmed that leukotoxin exposure caused secretion
of the active form of IL-1b, while LPS exposure mainly
increased the cell-associated pro-IL-1b (Figure 2f). A similar
effect could be shown already after 20min of leukotoxin
(10ng/ml) exposure (data not shown).
Caspase-1 and p38 inhibition, and their effects on
A. actinomycetemcomitans leukotoxin-induced activation
of human macrophages. Western blot analyses of cell
lysates from macrophages showed that exposure to
leukotoxin (1 or 10ng/ml) or LPS (100ng/ml) for 15- or
30-min activated phosphorylation of mitogen-activated
protein kinase (MAPK) p38 and the total levels of inhibitor
of NF-kBa (IkBa) were not affected by the leukotoxin (data
not shown). Time-course registration of p38 phosphorylation
in macrophages by ﬂuorescence-activated cell sorting
(FACS) showed a more rapid effect by the leukotoxin than
by the LPS (data not shown). Macrophages exposed to
10ng/ml leukotoxin for 5min showed a 10-fold increase in
phosphorylated p38 as compared with the unchallenged
control cells, while the levels of phosphorylated nuclear
factor kB (p65) (NF-kB (p65)) in these cells were not affected
(Figure 3a). To investigate the involvement of p38 and
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Cell Death and Diseasecaspase-1 in the leukotoxin-induced cell lysis and IL-1b
secretion from macrophages, the experiments were
conducted in the presence of selective inhibitors. Neither of
the two inhibitors used for p38 (SB 203580 or SKF-86002)
affected the leukotoxin-induced cell lysis or IL-1b secretion
(Figures 3b and c). In contrast, both selective inhibitors for
caspase-1 (Ac-YVAD-CMK or Z-VAD-FMK) reduced the
leukotoxin-induced lysis of macrophages to some extent
(Figure 3b) and the leukotoxin-induced IL-1b secretion to
levels similar to those found in unchallenged cells
(Figure 3c). The combination of inhibitors for caspase-1
(Ac-YVAD-CMK) and p38 (SB 203580) had no additive
inhibitory effect (Figures 3b and c). The presence of a p38
inhibitor (SB 203580) did not interfere with the secretion of
Figure 1 Analysis of cell survival, cell death, IL-18 and IL-1b secretion from human macrophages exposed to A. actinomycetemcomitans leukotoxin (Ltx) for 0–60min.
(a) Extracellular release of LDH, indicative of cell lysis, from human macrophages exposed to various concentrations of Ltx for 60min. Mean values±S.D. of three
experiments with differentmacrophagedonors. (b) Flow cytometricanalyses of uptake of YO-PRO-1(early apoptosismarker) and PI (late apoptosis/earlynecrosismarker) in
macrophages after Ltx exposure. Mean values±S.D. of macrophages from three experiments with MNLs obtained from different donors. (c) TEM analyses of macrophages
exposedtovariousconcentrationsofLtx(magniﬁcationof  3700).Meanvalues±S.D.ofcellswithtypicallynormal,necroticorapoptoticmorphologyfrommeasurementsof
four equally large ﬁelds on every grid with the following total number of cells in each group: 0 (n¼122 cells), 1 (n¼82 cells) and 10 (n¼79 cells). A representative cell from
each of these morphological categories is shown: normal (c-I), necrotic (c-II and c-IV) and apoptotic (c-III and c-V). ELISA quantiﬁcation of the secreted and cell-associated
IL-18 from human macrophages exposed to 10ng/ml Ltx for 0–60min. Mean values from three experiments with one macrophage donor. ELISA quantiﬁcation of secreted
IL-18(d)andIL-1b(e)fromhumanmacrophagesexposedto10ng/mlLtxfor60min.Meanvalues±S.D.fromeightexperimentswithdifferentmacrophagedonors.P-values:
0.03 (*) and 0.0003 (**) (two-tailed t-test, SPSS software) are indicated
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Cell Death and Diseaseany of the tested cytokines (IL-1b, tumor necrosis factor
(TNF)-a and interleukin-6 (IL-6)) from leukotoxin-challenged
macrophages, while this inhibitor (SB 203580) decreased the
E. coli LPS-induced cytokine secretion (data not shown).
Role of caspase-1, glycine, calcium, potassium and
oxidized adenosine-50-triphosphate (oATP) in leukotoxin-
induced macrophage lysis and IL-1b secretion. The
presence of a cytoprotectant (glycine) and the caspase-1
inhibitor (Ac-YVAD-cmk) partially inhibited the leukotoxin-
induced lysis of macrophages (Figure 4a). A combination of
these inhibitors caused an additive decrease in the
leukotoxin-induced macrophage lysis (Figure 4a). These
results indicated that leukotoxin-induced macrophage lysis
involved pore-formation as well as intracellular signaling
pathways. The presence of glycine had no effect on the
leukotoxin-induced IL-1b secretion from the challenged
macrophages (Figure 4b). Depletion of extracellular calcium
inhibited the IL-1b secretion caused by the leukotoxin, while
the degree of cell lysis remained unchanged (Figure 4c).
A similar effect was seen in samples with enhanced
extracellular potassium (Figure 4c) that limits the ability of
the cell to release intracellular potassium. Presence of oATP
inhibited both leukotoxin-induced cell lysis (Figure 4d) and
IL-1b secretion (Figure 4e) from macrophages. The
cell-associated levels of IL-1b were not affected by the
oATP (Figure 4e).
Effects of oATP on leukotoxin-exposed MNL. Analysis of
MNL structure (forward scatter (FSC)–side scatter (SSC))
examined by FACS showed a time-dependant selective
depletion of the macrophage population (with high FSC/SSC)
caused by the leukotoxin (10ng/ml) that was blocked in
presence of oATP (Figure 5a). Leukotoxin (10ng/ml) caused
also an enhanced FSC after 10min exposure, which was not
affected by the added oATP (Figure 5b). The PI-uptake
analysis by FACS showed that leukotoxin (10ng/ml) caused
a time-dependant cell death of MNL that was inhibited by
oATP (Figure 5c).
P2X7 receptor expression and ATP release of MNL. The
two different populations, R1 and R2, in the MNL-suspension
were gated (Figure 6a) and the composition of leuko-
cytes subsets (CD14þ, CD3þ and CD19þ) and P2X7R
Figure 2 Effectsof A. actinomycetemcomitansleukotoxin(Ltx) on humanmacrophageIL-1b productionandsecretion.(a) ELISAquantiﬁcationof thecell-associatedand
secreted IL-1b from macrophages exposed to 10ng/ml A. actinomycetemcomitans Ltx or 100ng/ml E. coli LPS (LPS) for 180min. Mean values±S.D. of seven experiments
with macrophages obtained from different donors. (b) Real-time RT-PCR quantiﬁcation of mRNA of IL-1b in macrophages exposed to Ltx (10ng/ml) or LPS (100ng/ml) for
60min in relation to the endogenous control GAPDH. Mean values±S.D. of three experiments from one macrophage donor. (c) Levels of mRNA for IL-1b in relation to the
endogenouscontrolGAPDHquantiﬁedbyrealtimeRT-PCRinmacrophagesexposedtoLtx(0–60min)orLPS(60min).Meanvalues±S.D.fromthreeexperimentsfromone
macrophagedonor.(d)ELISAquantiﬁcationofIL-1bsecretedfrommacrophagesexposedtoLtx(0–60min)orLPS(60min).Meanvalues±S.D.fromthreeexperimentsfrom
one macrophage donor. (e) ELISA quantiﬁcation of the cell-associated and secreted amounts of pro-IL-1b and IL-1b of macrophages exposed for 60min to 10ng/ml Ltx or
10ng/ml heat-inactivated (HI) Ltx (pretreated at 701C for 30min). Mean values±S.D. from three experiments from one macrophage donor. (f) Western blot analyses of cell
lysates(Pellet)andsupernatants(Sup)ofmacrophagesexposedto10ng/mlLtxor100ng/mlLPSfor60min.GAPDHwasusedasendogenouscontrol.Recombinanthuman
IL-1b (rh IL1b, left lower band) was used for veriﬁcation of the position of the 17kDa IL-1b (active form). Representative results from two experiments with different
macrophage donors are shown
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Cell Death and Diseaseexpression was documented by speciﬁc antibodies analyzed
by FACS (Figure 6b). The majority of the P2X7Rþ cells were
found in the R1-population, which also consisted of mainly
CD14þ cells, while the R2-population primarily was
CD3þ cells without P2X7R-expression (Figures 6b and c).
The high leukotoxin-sensitivity of the R1-population
was further indicated by PI-staining examined by FACS.
The leukotoxin-exposed (10ng/ml) MNL showed a time-
dependent decrease in living cells for the R1-population, but
less pronounced for the R2-population (Figure 6d). Presence
of oATP inhibited the leukotoxin-induced decrease in viable
MNL (Figure 6d). Further, luminescence analysis of ATP-
release from the macrophages showed a rapid extracellular
ATP release induced by the leukotoxin (1 and 10ng/ml)
(Figure 6e).
Discussion
This report shows new features of leukotoxin-induced cell
death of human macrophages that involves pro-inﬂammatory
stimulation. This newly discovered death mechanism resem-
bles the caspase-1-dependent programmed cell death desig-
nated pyroptosis.
21–22 Although major cell damage to the
macrophages was initiated by leukotoxin (r10ng/ml), these
cells were able to activate and secrete excessive amounts of
IL-1b during the death process. In relation to cells exposed to
E. coli LPS (one of the most widely used inducers of IL-1b
production and secretion), the leukotoxin-challenged cells
were able to induce 410-fold higher secretion of the active
IL-1b after a short exposure time (60min). This activation by
the leukotoxin was mainly mediated by caspase-1 activation
and was not correlated to any changes in the mRNA levels for
IL-1b. The leukotoxin-induced IL-18 secretion seemed to
follow the same pattern as for IL-1b. This is reasonable since
both cytokinesrequirecaspase-1activation fortheiractivation
and secretion. However, the leukotoxin-induced secretion of
IL-1b from macrophages was 30 times higher than the IL-18
secretion.
The results of this study indicate an irreversible loss of cell
membrane integrity of macrophages exposed to Z1ng/ml
leukotoxin, with a dose-dependent increase in affected cells
correlated to the concentration of leukotoxin. The different
cellular markers for both apoptosis and necrosis followed a
similar pattern of dose dependency and indicated a hetero-
geniccell populationwithregardtoleukotoxinsensitivity.TEM
conﬁrmed the presence of both apoptotic and necrotic cells in
the macrophage populations exposed to the leukotoxin.
The similar morphology of the affected cells exposed to
different concentrations of leukotoxin indicated a threshold
level for leukotoxin sensitivity for each cell subset. Each of the
affected cells activated signaling pathways that ﬁnally ended
up in cell death. An increase in leukotoxin enhanced the
proportion of affected cells. Moreover, the additive inhibitory
effect of a cytoprotectant (glycine) and a caspase-1 inhibitor
on leukotoxin-induced macrophage lysis indicated that this
process involved both pore-formation and activation of
intracellular signaling pathways. In addition, our results
showed that the leukotoxin-induced IL-1b secretion was
modiﬁed by blockage of calcium inﬂux or potassium efﬂux.
These modiﬁcations did not affect the leukotoxin-induced
cell lysis, which indicates that this cell lysis is independent of
IL-1b secretion.
Several bacterial products, such as LPS, are known to
increaseexpressionofpro-IL-1binmacrophages.
16However,
a secondary stimulus is needed to induce a substantial
secretion of the bioactive IL-1b. It has been shown that this
activationcanbeinducedbyvariousbacterialspeciesthrough
Figure 3 Caspase-1 and p38 inhibition, their effects on A. actinomycetemco-
mitans leukotoxin-induced lysis and IL-1b secretion from human macrophages.
(a) Flow cytometric analysis of p38 and NF-kB (p65) phosphorylation in human
macrophages exposed to 10ng/ml Ltx for 5min as compared with control cells.
Meanvalues±S.D.ofthreeexperimentsfrommacrophagesobtainedfromdifferent
donors. (b) Extracellular release of LDH and (c) ELISA quantiﬁcation of IL-1b
secretion of human macrophages exposed to 0, 3 or 10ng/ml leukotoxin for 60min.
The experiments were conducted without or with selective inhibitors: for p38
(SB 203580 or SKF-8600, 10mM) or caspase-1 (Ac-YVAD-CMK or Z-VAD-FMK,
100mM).Meanvalues±S.D.offourexperimentswithdifferentmacrophagedonors
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Cell Death and Diseaseactivation of the inﬂammasome (intracellular signal-induced
multiprotein complex) that leads to caspase-1 activation and
IL-1b secretion.
23 This secondary activation can be induced
by direct interactions of bacteria–bacterial compounds with
the inﬂammasome, such as proteins secreted by Salmonella
typhimurium
23 or Francisella tularensis invasion.
24 The other
system for stimulating this secondary activation has been
described through cell surface interactions as for Listeria
monocytogenes and Staphylococcus aureus.
23 The physio-
logical properties of the leukotoxin as a large protein that
involves interaction with a target cell receptor, the CD18
subunit of the b2-integrin,
25 indicates that this toxin also acts
through surface interactions.
Exposure of macrophages to leukotoxin also caused an
increase in the total IL-b protein in the macrophage cultures
(both cell-associated and secreted pro-IL-1b and IL-1b).
In other words, leukotoxin seemed to make more pro-IL-1b
available for activation than what normally exists in the cells,
and the toxin also acted as the secondary stimulus needed for
activation and secretion of IL-1b. Interestingly, we did not ﬁnd
any marked leukotoxin-induced production of IL-1b at the
mRNA level that could explain this increase in IL-1b protein.
The mechanism behind this phenomenon is not fully under-
stood. However, it might involve post-transcriptional changes
of the pro-IL-1b synthesis initiated by the leukotoxin-induced
cell stress. It has been proposed that signiﬁcant changes in
translational efﬁciency occur for IL-1b mRNA, because there
is a lack of correlation between IL-1b mRNA and protein
levels.
26 Leukotoxin-exposed macrophages showed a rapid
increase in phosphorylated p38, but this activation was not
correlated to cell lysis or IL-1b activation and secretion.
Moreover, the lack of activation of NF-kB p65 (Ser536), IkBa
and mRNA levels for IL-1b in leukotoxin-challenged macro-
phages indicated that the toxin mainly acted at a post-
transcriptional level. These ﬁndings are in contrast to the
LPS-inducedpathwayswherep38-activationisinvolvedinthe
production of IL-1b. In addition, LPS-induced IkBa phosphor-
ylation and degradation allows translocation of NF-kBt o
the nucleus, which can induce pro-inﬂammatory cytokine
production, including IL-1b.
27–28
The macrophages were sensitive targets for the leukotoxin
and this cell population consists of mainly CD14-positive cells
expressing P2X7R. This cell population responds to the
leukotoxin with a rapid extracellular release of ATP and an
increased cell volume (FSC). Prolonged leukotoxin exposure
caused pore formation and cell death conﬁrmed by increased
uptake of nucleic acid dyes (YO-PRO1 and PI) followed by a
complete collapse of the cells in this population. Addition of
the P2X7R antagonist oATP inhibited the leukotoxin-induced
cell death of the CD14þ population, which indicates
Figure 4 Role of caspase-1, glycine, calcium, potassium and oATP in leukotoxin-induced macrophage lysis and IL-1b secretion. Extracellular release of LDH (a) and
ELISA(b)quantiﬁcationofIL-1bsecretionfromhumanmacrophagesexposedto 0or10ng/mlofleukotoxinfor60min.Theexperimentsconductedwithout orwithcaspase-1
inhibitor (Ac-YVAD-CMK, 100mM) and/or a cytoprotectant (glycine, 5mM). (c) Experiments conducted in different buffers: physiological, without calcium or with enhanced
potassiumconcentration.Meanvalues±S.D.fromthreeexperimentswithdifferentmacrophagedoors.(dande)ExtracellularreleaseofLDH(d)andELISA(e)quantiﬁcation
of IL-1b secretion from human macrophages exposed to 0 or 10ng/ml of leukotoxin for 60min. The experiments conducted without or with oATP (500mM) added 30min
previous the toxin exposure. Mean values±S.D. from three experiments with different macrophage donors
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Cell Death and Diseaseinvolvement of P2X7R signaling in the leukotoxin-induced
pro-inﬂammatory monocyte/macrophage death. Prolonged
activation of the P2X7R by extracellular ATP have been
shown to open up pores in the cell membrane that allows
an uncontrolled ion exchange ending up in a similar pro-
inﬂammatory cell death.
17 The P2X7-R-dependent caspase-1
activation and IL-1b release in human monocytes/macro-
phages has been further evaluated in a recent publication.
29
In conclusion, this report shows that leukotoxin activates a
pro-inﬂammatoryresponse in human macrophages leading to
excessive and speciﬁc secretion of both IL-1b and IL-18. In
addition, we show for the ﬁrst time that this pro-inﬂammatory
cell deathwas inhibited byoATP,which indicates involvement
of the purinergic receptor P2X7 in this process.
29 This novel
virulence mechanism of theleukotoxin may havean important
role in the pathogenic potential of this bacterium and can be a
target forfuture therapeutic agents.
30,31 The speciﬁcmechan-
isms of purigenic receptor for A. actinomycetemcomitans
pathogenicity need further investigations.
Materials and Methods
Ethics. The blood was taken from donors visiting the University Hospital blood
bank in Umea ˚, Sweden. Informed written approval was given by all subjects, and
authorization for the study was granted by the Human Studies Ethical Committee of
Umea ˚ University, Sweden (y67/3, dnr 03-019).
Leukotoxin and leukocyte preparations. Leukotoxin was puriﬁed
from A. actinomycetemcomitans strain HK 1519 (JP2 clone), described in detail
Figure 5 Effects of oATP on leukotoxin-exposed MNL. The cell morphology (FSC/SSC) and viability (PI-uptake) of leukotoxin-exposed MNL were analyzed by FACS.
MNL were exposed to 10ng/ml leukotoxin with and without oATP (500mM) for up to 60min. (a) Distribution of FSC/SSC in MNL during leukotoxin exposure. (b) Histogram of
FSC of the exposed MNL (Co¼0min exposure, Ltx¼10min exposure). Mean FCS of the MNL population are indicated (c) PI-uptake in MNL during leukotoxin-exposure.
Mean values of PI-positive cells are indicated. All the ﬁgures show representative results from three experiments with different macrophage donors. Mean values±S.D. are
shown
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32 ThepuriﬁedleukotoxinwasbasicallyfreefromLPS(o0.001%of total
protein).
Human leukocyteswere isolated from an enriched leukocyte fraction (buffy coat)
of venous blood (from blood donors at the University Hospital blood bank in Umea ˚,
Sweden), as describedpreviously.
19 Mononuclear leukocytes (MNLs) were isolated
by isopycnic centrifugation in Lymphoprep (Nycomed AB, Lidingo ¨, Sweden). The
fraction containing MNLs was collected and the cells were washed three times
with phosphate-buffered saline (PBS) (250 g, 5min) to remove platelets. The cell
pelletwasthenre-suspendedinculturemediumRPMI-1640containing L-glutamine,
10% fetal bovine serum (FBS), and Penicillin–Streptomycin (Sigma-Aldrich,
St. Louis, MO, USA) to yield 5 10
6 cells/ml. This suspension was distributed into
50-mmPetri dishes (NUNC A/S, Roskilde, Denmark)at 15ml/dish and incubated at
371Ci n5 %C O 2 for 2h to allow the monocytes to adhere. The non-adherent
leukocytes were removed by two rinses with 10ml PBS. The adherent cells were
detached from the dish surface with a sterile cell scraper (Corning Incorporated,
Corning,NY, USA), washedtwice with PBS and re-suspended in culture mediumto
yield 10
6 cells/ml. Further, 1ml of this suspension was distributed to 2cm
2 culture
dishes (NUNC) and cultured for 20h at 371Ci n5 %C O 2 to equilibrate the cells.
Before experimentation, the culture medium was replaced by fresh medium. The
adherent MNLs obtained by this procedure are termed macrophages.
19–20
Cell survival and cell death analysis
Cytolysis. Leukotoxin-induced cytolysis was determined by the release of the
cytosol enzyme LDH as described earlier.
18 The cells were incubated for 60min at
371C in the presence of various concentrations of leukotoxin. The activity of the
enzyme released from damaged cells into the supernatant was measured and
expressed as a percentage of the total LDH activity released from cells lysed by
exposure to 0.1% Triton X-100 for 60min. In order to determine the role of calcium
inﬂux and potassium efﬂux, experiments were performed in buffers without calcium
or enhanced potassium, in accordance to Moudy et al.
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Yo-PRO-1 and PI uptake quantiﬁed by FACS. The macrophages were
incubated in culture medium for 60min, at 371C in the presence of 1 or 10ng/ml
A. actinomycetemcomitans leukotoxin. Macrophages in plain culture medium
served as controls. These cells were further analyzed for early detection of
apoptosis/necrosis. The experiment was ended on ice, and Yo-PRO-1 and PI was
added according to the Vybrant Apoptosis Assay Kit #4 protocol (Molecular
Probes/Invitrogen Labeling and Detection, Eugene, OR, USA). These dyes were
incubated for 30min, the cells were detached with a sterile cell scraper (Corning
Incorporated), transferred to FACS tubes and analyzed by FACS as soon as
possible using 488nm excitation with ﬂuorescence emission at 530nm (e.g., FL1)
and 4575nm (e.g., FL3) (Calibur, Becton Dickinson Immunocytometry Systems,
Becton Dickinson, Franklin Lakes, NJ, USA).
Transmission electron microscopy. The macrophages were obtained as
described above and were further treated with 1 or 10ng/ml leukotoxin for 1h.
Macrophages alone were used as a negative control. All samples were ﬁxed with
2.5% glutaraldehyde for at least 30min at room temperature and then washed in
sodium cacodylate buffer and postﬁxed in 2% osmium tetroxide in the same buffer
for 1h. The samples were centrifuged and the pellets were dehydrated and
embedded in Epoxy resin LX-112. The embedded samples were cut into ultra-thin
sections, placed on grids and stained with uranyl acetate and lead citrate. Sections
were examined with a transmission electron microscope (Philips 420, Fei, Hilsboro,
OR,USA).Themeasurementsoffourequallylargeﬁeldsoneverygridweredoneto
count percentages of normal, apoptotic and necrotic cells in each sample.
Distinguishing features for apoptosis were chromatin condensation and DNA
fragmentation (karyorrhexis); features of necrosis were plasma membrane
disruption and nuclear disintegration as described previously.
34
Cytokine quantiﬁcation
ELISA. The macrophages were exposed to bacterial stimuli as described above.
TheamountsofIL-1b,IL-6andTNF-asecretedintotheculturemedium,orretained
intracellularly in the macrophages, were determined by ELISA using DuoSet kits
(R&D Systems Inc., Minneapolis, MN, USA). IL-18 was quantiﬁed by a kit from
Medical & Biological Laboratories Co., Ltd. (Nagoya, Japan). To obtain maximum
release of the intracellular cytokines, the cells were lysed with 0.1% TritonX-100 for
60min. All samples were stored at –801C pending analysis. The maximum level of
active IL-1b (both secreted and cell associated) in the leukotoxin-challenged
macrophages (10ng/ml) was set at 100 %, while the maximum level of IL-6 and
TNF-a were obtained from the E. coli LPS-challenged cells and were set at 100%.
To allow discrimination between pro-IL-1b and active IL-1b the Quantikine Kits
(R&D Systems Inc.) were used. Speciﬁcity tests of the Quantikine Kits showed
negligible cross-reactivity of pro-IL-1b with IL-1b and vice versa. For all ELISA kits
the procedures were done according to the manufacturer’s protocol.
Western blot. Detection of IL-1b in supernatants and cell pellets was also
assayed by an immunoblot technique that allows discrimination of the biologically
inactive pro-IL-1b (31kDa) and the active protein (17kDa).
19 Brieﬂy, the proteins in
the supernatants and cell pellets were boiled in sample buffer, separated by
SDS-PAGE, transferred to a Polyscreen membrane (NEN Life Science Products,
Boston,MA,USA)andincubatedwithpolyclonalrabbitanti-humanIL-1bantibodies
(R&D Systems Inc.), which recognize both pro- and active IL-1b. For endogenous
control a polyclonal rabbit anti-human GAPDH (R&D Systems Inc.) was used. As a
secondaryantibody,horseradishperoxidase-conjugatedgoatanti-rabbitIgG(Dako,
Glostrup, Denmark) was used. Recombinant human IL-1b was used to verify the
positionoftheactiveIL1b (Sigma-Aldrich).Theimmunoreactiveproteinbandswere
enhanced by chemiluminescence technique (Pierce, Rockford, IL, USA) and
visualizedusingChemiDocXRS(BIORADLaboratoriesAB,Sundbyberg,Sweden).
Effect on expression of IL-1b mRNA
RNA extraction and cDNA synthesis. Total RNA was extracted from
2 10
6 macrophages per well, from experiments in 12-well plates (NUNC) by the
RNAqueous-4PCR kit (Ambion Inc., Austin, TX, USA), according to the
manufacturer’s protocols. Further, extracted total RNA was treated with DNase I
toeliminategenomicDNA.TheRNAwasquantiﬁedbyspectrophotometerandused
for the complementary deoxyribonucleic acid (cDNA) synthesis; 0.1mg of total RNA
Figure 6 P2X7 receptor expression and ATP release of MNL. (a–c) show
unchallenged MNL examined by FACS and (d and e) show leukotoxin-exposed
MNL. (a) Population identiﬁcation (R1 and R2) of MNL based on FCS/SSC
characteristics. A representative dot-plot is shown. (b) Distribution of cells with
different surface markers in the two gated populations (R1 and R2). Mean
values±S.D. from three different MNL donors are shown. (c) Illustration of P2X7R
expression in R1 and R2 by representative histograms. (d) Number of viable cells
(PI-negative) in the two different MNL populations (R1 and R2) analyzed by
FACS during leukotoxin exposure (10ng/ml) with and without oATP (500mM).
(e) ATP-release from the macrophages exposed to the leukotoxin (1 and 10ng/ml)
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Synthesis Kit (Roche Applied Science, Mannheim, Germany) using AMV reverse
transcriptase and oligo-p(dT)15 primers. After incubation at 251C for 10min and at
421Cfor60min,theAMVreversetranscriptasewasdenaturatedat991Cfor5min,
followed by cooling to þ41C for 5min. The cDNA was kept at –201C until PCR
analysis.
Quantitative real-time reverse transcription polymerase chain
reactions (RT-PCRs). Quantitative real-time RT-PCR analyses were
performed using Taqman kinetics with ﬂuorescence labeled probes (reporter
ﬂuorescent dye VIC at the 50 end and quencher ﬂuorescent dye TAMRA at the
30 end) (Applied Biosystems, Foster City, CA, USA): human GAPDH assay
ID Hs00266705_g1, human RPL13A assay ID Hs03043885_g1 and human IL-1b
assay ID Hs00174097_m1. In each reaction, cDNA was diluted 20-fold with
nuclease-free water and ampliﬁed using the TaqMan Universal PCR Master Mix,
300nM of each primer and 100nM of probe. The reaction conditions were an initial
step of 2min at 501C and 10min at 951C, followed by 40 cycles of denaturation at
951C for 15s and annealing/extension at 601C for 1min. The ampliﬁcations were
performed using the ABI PRISM 7900 HT Sequence Detections System and
software (Applied Biosystems). No ampliﬁcations were detected in samples where
the RT reaction had been absent. To control for variability in ampliﬁcation because
of differences in starting mRNA concentrations, GAPDH or RPL13A were used as
endogenous controls. The relative expressions of IL-1b mRNAs were computed
fromtheIL-1bCtvaluesandGAPDHorRPL13ACtvaluesusingthestandardcurve
method. Ct values for GAPDH and RPL13A were conﬁrmed not to vary over time
or because of treatment.
Effect on p38 MAPK, NF-jB (p65) and IjBa. Speciﬁc antibodies were
used to test the activation of the MAPK p38, NF-kB and IkBa. Phospho-p38 MAP
kinase rabbit pAb (thr180/tyr182) #9211; total p38 MAP kinase rabbit pAb #9212;
and phospho-NF-kB p65 (Ser536) (93H1) rabbit mAb (Alexa Fluor 647 Conjugate)
#4887 were obtained from Cell Signaling Technology Inc. (Danvers, MA, USA).
Rabbit anti-IkBa was obtained from (Santa Cruz Biotechnology, Santa Cruz, CA,
USA). All the procedures and dilutions of the antibodies for western blot and FACS
analyses were according to the manufacturer’s protocol (Cell Signaling Technology
Inc.). In western blot analysis, the cell lysates were prepared in accordance with the
manufacturer’s protocol (Cell Signaling Technology Inc.), and a horseradish
peroxidase-conjugated goat anti-rabbit IgG (Dako) was used as a secondary
antibody. In FACS analysis, a rabbit IgG, chromatographically puriﬁed isotype
(Zymed Laboratories Inc., San Francisco, CA, USA) was used as nonspeciﬁc
negativecontrol.Further,a secondaryﬂuoresceinisothiocyanate(FITC)conjugated
goat anti-rabbit (Rockland Immunochemicals Inc., Gilbertsville, PA, USA) was used
in FACS analysis. After following the recommended step in the manufacture’s
protocol, the ﬁnal volumes 0.5ml with a ﬁnal concentration of 10
6 cells per tube,
were analyzed by FACS using 488nm excitation with ﬂuorescence emission at
530nm (e.g., FL1) (Calibur, Becton Dickinson Immunocytometry Systems).
Inhibitionofleukotoxin-inducedcelllysisandIL-1bsecretion. All
inhibitors used in this study were diluted in dimethyl sulphoxide (DMSO) and added
to the cell cultures 15min before leukotoxin or LPS exposure. The ﬁnal
concentrations of DMSO in the cell cultures containing these inhibitors was 0.1%,
and in these experiments DMSO (0.1%) was also added to the corresponding
control groups (without inhibitor). The inhibitors used were as follows: caspase-1
inhibitors (Ac-YVAD-CMK (C24H33CIN4O8) or Z-VAD-FMK (C22H30FN3O7)
(Calbiochem, La Jolla, CA, USA) at a ﬁnal concentration of 100mM, p38 MAPK
inhibitors(SB203580(C21H16N3OSF)or SKF-86002(C16H12FN3S)(Calbiochem)at
aﬁnal concentration of 10mM, andGlycine(NH2CH2COOH)at a ﬁnalconcentration
of 5mM (water soluble). In order to determine the role of calcium inﬂux
and potassium efﬂux, experiments were performed in buffers without calcium or
enhanced potassium, in accordance to Moudy et al.
33 Incubations were also
performed in presence of leukotoxin (10ng/ml) with or without oATP (500mM)
(Sigma-Aldrich) added 30min previous the toxin.
Cell characterization by FACS and ATP release
Flow cytometric analyzes. MNL were isolated from buffy coat as described
washed and resuspended in PBS do a density of 10
6 cells/ml. The cells were
characterized based on their different distribution in light scatter (SSC and FSC)
by FACS, (Calibur, Becton Dickinson). The two distinct populations (G1 and G2)
were characterized with speciﬁc ﬂuorescein (FITC)-conjugated antibodies for
expression of cell surface receptors: CD14 (Clone Tu ¨K4), CD3 (Clone UCHT1)
CD19 (Clone HD37) (all from DakoCytomation, Copenhagen, Denmark) and P2X7
(Rabbit polyclonal) (Alomone Labs, Jerusalem, Israel). Analyzes were performed in
accordancetothemanufacturer’sprotocolasdescribed previously(Kelketal., 2008).
Incubations were also performed in presence of leukotoxin (10ng/ml) with or without
oATP (500mM) (Sigma-Aldrich) added 30min previous the toxin. To discriminate
between viable and dead cellsPI (75mM) (Sigma-Aldrich) was added to the mixtures
before analyzes. Twenty thousand cells from each sample were analyzed.
ATP release. Release of ATP was analyzed in culture supernatants with a
commercial kit (Chrono-Lume 395) in accordance to the manufacturer’s protocol
(Chrono-Log Corp., Havertown, PA, USA). Analyzes were performed in EC-buffer
and the supernatants immediately transferred to  201C and stored frozen until
quantiﬁcation in a luminometer (Becton Dickinson).
Statistical analysis. Mean values and S.D. are shown in the ﬁgures and
tables. The statistical analyses were done in the SPSS software (IBM, Somers, NY,
USA) by using t-test. P-values of o0.05 were considered indicative of statistically
signiﬁcant differences.
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